Pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of DMT.
View all
Geneseeq Technology
Toronto, Canada · Series D
Cytodyn
Vancouver, United States · Post IPO Equity
Zymeworks
Vancouver, Canada · Post IPO Equity
Triumvira Immunologics
Hamilton, Canada · Series A
Verve Therapeutics
Cambridge, United States · IPO
Helix
San Mateo, United States · Series C
Guardant Health
Redwood City, United States · Venture
Callitas Therapeutics
Vancouver, Canada
AbCellera
Vancouver, Canada
Scipher Medicine
Waltham, United States · Series D
Natera
Austin, United States · Post IPO Equity
Genevant Sciences
Vancouver, Canada